ExodusPoint Capital Management »

4d Molecular Therapeutics In shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $294k 39k 7.50
2023-09-30 $373k 29k 12.73
2020-12-31 $1.4M 33k 41.45

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In